...
首页> 外文期刊>Molecular and Cellular Endocrinology >Alpha1-adrenergic regulation of peptidylglycine alpha-amidating monooxygenase gene expression in cultured rat cardiac myocytes: transcriptional studies and messenger ribonucleic acid stability.
【24h】

Alpha1-adrenergic regulation of peptidylglycine alpha-amidating monooxygenase gene expression in cultured rat cardiac myocytes: transcriptional studies and messenger ribonucleic acid stability.

机译:在培养的大鼠心肌细胞中肽基甘氨酸α-酰胺化单加氧酶基因表达的α1-肾上腺素调节:转录研究和信使核糖核酸稳定性。

获取原文
获取原文并翻译 | 示例

摘要

Peptidylglycine alpha-amidating monooxygenase (PAM; EC 1.14.17.3) is a bifunctional protein containing two enzymes that act sequentially to catalyse the alpha-amidation of neuroendocrine peptides. Previous studies have demonstrated that alpha-adrenergic stimulation results in an increase in intracellular volume and protein content of cultured neonatal rat myocardial cells. The present study examined the regulated expression of PAM during alpha-adrenergic stimulation. Alpha1-adrenergic stimulation activates the expression and release of PAM from myocytes. Following phenylephrine treatment, myocardial cells displayed a several fold increase in PAM activity, and a 2-4-fold increase in the steady state levels of PAM mRNA. This effect of alpha-adrenergic stimulation was dependent on the concentration and duration of exposure to the agonist, and displayed alpha1-adrenergic receptor specificity. The transcription rate experiments indicated that these alpha-adrenergic effects were not due to increased PAM gene activity, suggesting that a post-transcriptional mechanism was involved. The most common mechanism of post-transcriptional regulation affects cytoplasmic mRNA stability. Cardiomyocytes cultures from atria and ventricles in the presence of 5,6 dichloro-1-beta ribofuranosyl benzamidazole (DRB) showed that phenylephrine treatment increased the half-life of PAM mRNA from 13 +/- 1 to 21 +/- 1 h in atrial cells and from 8 +/- 1 to 12 +/- 1 h in ventricle cells. Analysis of nuclear RNA with probes specific for PAM intron sequences shows that increased PAM expression after phenylephrine treatment was not due to intranuclear stabilisation of the primary transcript. Protein kinase C inhibitors H7 and GF109203x, completely blocked the phenylephrine stimulated PAM expression. These results suggest that alpha-adrenergic agonist induces PAM mRNA levels by increasing its stability in the cytoplasm. They indicate that PAM gene expression augments through a H7 and GF109203x sensitive pathway, involving the activation of protein kinase C.
机译:肽基甘氨酸α-酰胺化单加氧酶(PAM; EC 1.14.17.3)是一种双功能蛋白,其中包含两种酶,这些酶顺序发挥作用来催化神经内分泌肽的α-酰胺化。先前的研究表明,α-肾上腺素刺激导致培养的新生大鼠心肌细胞的细胞内体积和蛋白质含量增加。本研究检查了α-肾上腺素刺激过程中PAM的调控表达。 Alpha1-肾上腺素能刺激激活PAM的表达并从肌细胞中释放出来。苯肾上腺素治疗后,心肌细胞的PAM活性增加了几倍,而PAM mRNA的稳态水平则增加了2-4倍。 α-肾上腺素刺激的这种效应取决于激动剂暴露的浓度和持续时间,并显示出α1-肾上腺素受体特异性。转录速率实验表明,这些α-肾上腺素的作用不是由于增加了PAM基因的活性,提示参与了转录后机制。转录后调控的最常见机制影响细胞质mRNA的稳定性。在存在5,6二氯-1-β呋喃核糖基苯并咪唑(DRB)的情况下,心房和心室的心肌细胞培养表明苯肾上腺素治疗可使PAM mRNA在心房中的半衰期从13 +/- 1增至21 +/- 1 h细胞和心室细胞中的8 +/- 1至12 +/- 1 h。用对PAM内含子序列有特异性的探针对核RNA的分析表明,去氧肾上腺素处理后PAM表达的增加并不是由于初级转录本的核内稳定。蛋白激酶C抑制剂H7和GF109203x完全阻断了去氧肾上腺素刺激的PAM表达。这些结果表明,α-肾上腺素能激动剂通过增加其在细胞质中的稳定性来诱导PAM mRNA的水平。他们表明,PAM基因表达通过H7和GF109203x敏感途径增强,涉及蛋白激酶C的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号